Plasma activities of creatine kinase (CK) and a-hydroxybutyrate dehydrogenase (HBD) were measured after permanent coronary artery occlusion in the dog. Cumulative release of enzymes in plasma was calculated from these data by using a previously validated two-compartment model for circulating enzymes. Regional myocardial ischemia was measured by injection of radiolabeled microspheres. After 48 hours, the dogs were killed, and a detailed map of left ventricular enzyme activity was obtained from 108 tissue samples. Cumulative release into plasma of CK and HBD was 96±20% and 112 +26%, respectively, of the total activities depleted from the heart (mean±+SD, n=11). The scatter in these values is inherent to the calculations, and it is concluded that both enzymes are recovered completely in plasma and, thus, can be used as quantitative markers of injury. Discrepancies between this result and earlier reports on the recovery of CK are only partly apparent and can be explained partly by underestimation of the elimination rate of CK from plasma, irregardless of tissue edema and incomplete extraction of enzyme activity from tissue. (Circulation 1990;81:649-659) 
Etstimation of the extent of ischemic myocardial injury from the release of cardiac enzyme in plasma has become normal clinical practice. Recently, this technique has been used, for instance, in the evaluation of early thrombolytic therapy of acute myocardial infarction. '-3 In such studies, enzymatic infarct size was found to be a sensitive parameter allowing detailed classification of the extent of injury. Several clinical studies also have produced convincing correlations between enzymatic and histologic estimates of infarct size. [4] [5] [6] [7] After permanent coronary occlusion in the dog, however, only about 15% of the total creatine kinase (CK) activity depleted from the heart was recovered in plasma,8 and it was shown that even a limited variability in this recovery would cause large errors in the estimates.9 Such variability was indeed demonstrated.'0411 Moreover, it was reported that this figure of 15% was changed significantly after interventions such as reperfusion12 and lymphatic obstruction. 13 The doubts raised by these experimental results have prevented general acceptance of enzymatic estimation of infarct size, despite its easy applicability.
CK is a rather labile enzyme with a limited thermostability in plasma and lymph.13 Denaturation of CK before or during transport from heart to plasma, thus, could explain a low and variable recovery. In See p 707 contrast, the myocardial isoforms of the enzyme lactate dehydrogenase (LDH) show a marked thermostability that has been used in clinical practice by the determination of "heat stable" LDH activity. These isoenzymes can be conveniently determined by their specific a-hydroxybutyrate dehydrogenase (HBD) activity.
The present study was undertaken to investigate whether the HBD and CK activity depleted from the heart is indeed recovered completely in plasma. A previously developed two-compartment model for circulating enzymes was used for the calculation of cumulative release of HBD and CK in plasma. Complete recovery was found for both enzymes and the factors responsible for the discrepancies in the literature were analyzed.
Methods

Animal Preparation and Experimental Protocol
Mongrel dogs of either sex and unknown age were used. Before the experiments, animals were housed individually for at least 2 weeks. Only animals appearing healthy with normal plasma enzyme activities were used. They were allowed water ad libitum and were fed standard commercial dog food (Doko, Trouw, Putten, The Netherlands) throughout the experimental period.
Animals were premedicated with 0.5 ml/kg of a mixture containing 10 mg fluanisone and 0.3 mg fentanyl citrate/ml. Anesthesia was induced intravenously with sodium pentobarbital (10 mg/kg) and, after endotracheal intubation, was maintained with halothane (0.5% inspiratory volume). The lungs were ventilated with a positive pressure respirator (Pulmomat) adjusted on the basis of blood gas values (Pco2, 35-45 mm Hg; Po2, >120 mm Hg; pH, 7. 35-7.45 ). The thorax was entered through the fifth intercostal space. The pericardium was opened, and the left anterior descending coronary artery (LAD) was dissected, distal to the first diagonal branch. A snare (Mersilene; 3 metric) was placed around the LAD, and both ends were inserted into a polyethylene tube (Clay Adams Intramedic PE 240; i.d. 1.67 mm). To avoid arterial damage, this tube was provided with a silastic tip that was glued to a small silastic flap sutured to the epicardium. The snare was fixed in the tube so that an outward pull over a distance of 2 cm caused complete ligation of the LAD.
A catheter (Tygon S 50 HL 1/16Xl/8 in.) was inserted through the auricle into the left atrium for microsphere injection, collection of blood samples, and administration of medication. In eight dogs, a similar catheter was implanted in the descending aorta to obtain a reference blood sample for the microsphere technique. The polyethylene tube and the catheters left the thoracic cavity through the intercostal incision and were sutured to the lateral rib. Then they were tunneled underneath the skin and extelorized at a site between the scapulae. The thorax and the skin were closed, and the dogs received 1 g ampicillin i.m. They were allowed to recover for 1 week. It was verified that postoperative elevations of plasma enzyme activities had disappeared.
Before coronary occlusion, the dogs received lidocaine (100 mg) and an analgesic (0.3 mg buprenorpine) and were sedated with 3 ml of a mixture containing 10 mg oxycodon, 1 mg acepromazine, and 0.5 mg atropine sulfate/ml. This medication was repeated every 3 hours until 24 hours after occlusion. Occlusion of the LAD was obtained by pulling the snare 2 cm out of the polyethylene tube and fixing it in this position. Successful occlusion was evidenced by ST-segment elevation in the electrocardiogram and inspection at the site of occlusion after the dogs were killed 48 hours later. After 24 hours, the dogs were transferred to their normal housing.
Samples of 4 ml blood were obtained before occlusion, every 3 hours during the first 24 hours after occlusion, and every 6 hours thereafter. Clotting was prevented by dry heparin. Samples were immediately centrifuged for 15 minutes at 1,000g. The supernatant plasma was collected, avoiding contamination APEX FIGURE 1. Schematic of left ventricle divided into 108 tissue samples. Epicardial and endocardial tissue are indicated by even and odd numbers, respectively. Site of occlusion in the second slice is indicated by a black dot. Infarcted area is shaded.
with sedimented blood cells, and stored at -80°C until determination of plasma enzyme activities. New samples were obtained if hemolysis was detected by visual inspection.
After 48 hours, the animals were killed with an overdose of sodium pentobarbital. The heart was excised, rinsed, and frozen at -20°C. Within 5 days, the hearts were further processed as described below.
Determination of Myocardial Enzyme Activities
The heart was quickly thawed in running cold water. The right ventricle and adhering fat were removed. The left ventricle was opened from base to apex along the ramus marginalis in the posterior ventricular wall and cut into five slices 1-2 cm thick ( Figure 1 ). The four upper slices were divided into 12 and the fifth apical slice into six transmural samples, each divided again into endocardial and epicardial parts. Samples remained at room temperature for less than 30 minutes to prevent enzyme denaturation. The 108 resulting tissue samples were weighed (0.3-2 g) and stored at -80°C.
Myocardial enzyme activities were determined within 6 weeks after storage. Samples were allowed to thaw at room temperature and homogenized in 20 ml Tris-HCl buffer (0.05 M; pH, 8.5) in three bursts of 7 seconds, with intervals of 7 seconds, with a Janke & Kunkel Ultraturrax (type 18-10). The buffer contained 0.05 M NaCI, 15 ,uM pyridoxal-5-phosphate, and 3 mM mercaptoethanol. After homogenization, samples were sonified for 3 minutes, in 5-second bursts at 5-second intervals, with an MSE Mark II 150-W disintegrator. During homogenization and sonification, the tubes were kept on ice. From the thoroughly mixed suspension, a 2-ml sample was taken for the determination of dry weight. The remaining suspension was centrifuged at 1,000g for 10 minutes, and the supernatant was assayed for enzyme activities. It was found that samples up to 5 g wet wt could be processed in this way with complete extraction of tissue enzyme activity. For larger samples, incomplete extraction occurred. For instance, control samples of 10 g homogenized in 40 ml buffer showed values of 78±5% (mean+SD, n=4) of the activities obtained from samples of 1 g. Apart from sample size, thorough tissue destruction also is crucial. In eight whole left ventricles that were minced and homogenized in a Braun Blendor (type MX, four 15-second bursts), only 46±7% and 94±6% (mean± SD) of the activities of CK and HBD, respectively, as determined in biopsies from the same hearts, were extracted. Dry weight was determined by lyophilization in a Leyboldy Heraeus vacuum freeze-drier (Type GT2) after previous freezing of samples at -80°C.
Determination of Regional Myocardial Blood Flow
Regional myocardial blood flow was determined with tracer microspheres as described in detail before.14 Just before occlusion, and 15 minutes and 48 hours after occlusion, 3-5 x 106 microspheres (New England Nuclear Corp.; diameter, 15 ± 1.5 ,um) labeled with cerium 141, ruthenium 103, or niobium 95 were injected into the left atrium, and a reference blood sample was obtained from the descending aorta. The 108 tissue samples were scanned for radioactivity in a gammacounter (Packard Multichannel Analyzer), and regional myocardial blood flow was calculated (ml/min/g).14 Only four to six samples at a time were scanned to ensure that they remained frozen during counting.
Determination of Enzyme Activities
The activities of CK (EC 2.7.3.2) and HBD were determined spectrophotometrically using commercially available test kits (NAC-activated CK test from Merck Diagnostica and optimized HBDH test from Boehringer) and a centrifugal analyzer (Cobas Bio System, Hoffman-La Roche). The HBD assay is based on the specific activity of the myocardial isoenzymes LDH1 and LDH2 of lactate dehydrogenase (LDH; EC 1.1.1.27) toward a-ketobutyrate instead of pyruvate, the natural substrate of LDH.
Activities were determined in duplicate at 250 C and expressed in micromoles of substrate converted per minute (U).
Calculation of Total Enzyme Release in Plasma
Cumulative release of enzyme activity per liter of plasma from the time of occlusion (t=0) up to time t was calculated from the relation:
It is based on a two-compartment model with intravascular input of enzyme activity and elimination of activity from plasma with a constant fractional catabolic rate (FCR). Extravasation of activity occurs with a constant fractional transcapillary escape rate (TER) and return of activity to plasma with a constant fractional extravascular return rate (ERR). The plasma activities C(t) at time t are obtained by subtracting the preocclusion steady-state plasma activities from the actually measured values. Values of C(t) as well as Q(t) are expressed as liters of plasma (units/l). The two-compartment model mainly has been developed in studies on the turnover and distribution of radiolabeled plasma proteins (See Reference 30 for a review). For the description of circulating enzymes, it has been validated with intravascular and intramuscular injections of enzyme preparations in the dog,15-17 and values of TER= 0.032/hr and ERR=0.068/hr are used. Values of FCR determined in unsedated dogs were FCRCK= 0.36±0.08/hr'5 and FCRHBD=0.41 +0.12/hr16 (mean+SD). Total release of activity was calculated by multiplication of Q(48) with plasma volume obtained from body weight and a fixed mean value of 47 ml/kg. 18 A possible effect of medication during the first 24 hours after occlusion on the values of FCR was checked in six dogs. These animals were sedated again after 48 hours and given an intravenous bolus injection of an enzyme preparation obtained from anoxically incubated myocardial tissue.15. The rate of elimination of CK and HBD activity was determined from five plasma samples obtained 15, 30, 40, 90, and 120 minutes after injection.
Results
Occlusion of the LAD was performed in 16 dogs. Rupture of the LAD occurred in one dog 10 hours after occlusion, and three dogs died within 24 hours. One dog did not develop an infarction as evidenced by the absence of a significant flow reduction and unaltered plasma enzyme activities. Data from the remaining 11 dogs are presented. Microspheres were injected in the first six dogs listed in each table. Figure 2 presents an example of enzyme depletion after 48 hours and flow reduction 15 minutes after occlusion, measured in the same heart. A close correlation between both parameters is apparent, and some general trends are also shown in this figure. The first, basal slice of myocardium contained some connective tissue and fatty infiltrates, resulting in irregularities in tissue enzyme content and blood flow. The second slice contained the site of occlusion and was usually only focally depleted. Control for enzyme content and blood flow were therefore CK and 13% for HBD. Variation in individual hearts obtained from the mean values in the samples [25] [26] [27] [28] was less (i.e., only 6-7% for both enzymes) ( Table 1 ). and 45-48 ( Figure 1 ) from this slice. Total variation Because of the close correlation between flow in enzyme content of the control areas was 11% for reduction and enzyme depletion and the small vari- ation in enzyme activity within the same heart, the ischemic area was defined as the area in slices 2-5 ( Figure 1 ) between and including the first sample to the left and the first sample to the right with more than 15% depletion in CK and HBD activities, compared with the control activities in the same heart. Table 1 shows that a large range of enzyme depletions was obtained even though the site of occlusion was standardized. This phenomenon has been related to the large variability in canine coronary collateral flow.19 Figure 3 shows mean enzyme depletion and blood flow in slice 3 measured 48 hours after occlusion and expressed as a percentage of control values in the same heart. The mean depletion of enzyme activity in the central infarcted area is about 60% in the endocardium and about 40% in the epicardium. This depletion is only partly apparent and caused by the development of edema, as discussed below. Figure 3 suggests a gradual transition from nondepleted to severely depleted tissue. However, this gradual change is mainly the effect of averaging. As shown in Figure 2 , the transitions occur rather sudden, which is also illustrated in the inserts of Figure 3 showing the mean activity gradients in the border areas. Figure 4 presents the degree of edema in slice 4, expressed as the percentage increase of wet weight (i.e., as 100(1-FDW/FDWo) with FDW and FDWo the fraction of dry weight in infarcted and control tissue, respectively. Development of edema in the infarcted area causes an apparent flow reduction in the first, preocclusion, flow measurement. It follows from Figure 4 that about one half of this apparent flow reduction in the central infarcted area can be explained by the development of edema, and a similar fraction has to be attributed to loss of microspheres from the infarcted area. These results are in agreement with earlier reports in the literature.20-22 A major part of the flow recovery in the first 48 hours after occlusion in Figure 3 , thus, is only apparent and actually the result of edema and loss of microspheres. The remaining true recovery is mainly located in the epicardium as has been reported before. 23 In Table 1 , the total depletion of activity from the infarcted area calculated from wet weight as well as from dry weight is presented. For heart 1, for example, the total dry weight of the infarcted area was 3.64 g, and preocclusion CK content per gram of dry weight was estimated from the control area as 1,424/ 0.18=7,911 units/g. Accordingly, total depletion estimated from dry weight was (3.64x7,911)-19,282= 9,514 units. Figure 5 shows the elimination of CK and HBD from plasma in six sedated dogs. Strictly first-order elimination was observed with fractional disappearance rates of 0.51+0.13/hr for CK and 0.36+0.07/hr for HBD. These values are not significantly different from the initial disappearance rates of 0.45+±0.09/hr ENZYME ACTIVITIES hence, the values for FCRCK and FCRHBD as found before ("Methods") were used in the calculations. In Figure 6 , mean plasma enzyme activities and cumulative release of CK and HBD, as expressed in gram-equivalents of myocardium per liter of plasma, are shown. The latter values were obtained by dividing the calculated values of Q(t) by the mean enzyme content per gram of wet weight (i.e., 1,421 units/g for CK and 179 units/g for HBD) ( Table 1 ). It follows from Figure 6 that the estimates of the extent of injury obtained from both enzymes are not significantly different.
It follows from Table 2 that the recoveries calculated from dry weight do not differ significantly from 100%, although considerable scatter is apparent. This scatter is inherent to these calculations. Variation in enzyme content of the control area is 6-7%. As the overall depletion of the infarcted area is only about 40%, this variation introduces a 15-18% error in calculated total depletion. Values of FCR show about 20% variation between dogs and the use of a fixed mean value for FCR will thus cause a 20% error in calculated cumulative release. Therefore, both quantities involved in the calculation of the recovery, the depleted as well as the released activity, contain errors of about 20%. Assuming that these two errors are random and independent, an overall error in calculated recovery of \/f(O270)+ (20) ]=28% is to be expected, in accordance with the results shown in Table 2 . Despite this large scatter, the correlations between depleted and released activities are high as shown in Figure 7 . figure. First, the release of CK in plasma was calculated with a one-compartment model, using the apparent disappearance rate constant kd=0.29/hr for FCRCK.27 Second, tissue CK depletion was calculated from wet weight. Third, CK depletion was calculated not from the samples in the infarcted area but from the summed activity in the whole ventricle. 27 The first modification results in underestimation of CK release in plasma with about 20%, the second in overestimation of tissue CK depletion also with about 20%, and the third in an increased scatter in calculated depletion ("Discussion"). The effects of two additional modifications are shown in the right-hand panel of Figure 8 . Measurement in whole ventricular homogenates would increase the CK depletion by a factor of about 2 ("Methods"); it is also assumed that infarcted tissue loses only 70% of its original CK contents,27 which implies that infarct size in gramequivalents is obtained by multiplication of the depleted activity with a factor of 100/70= 1.43.27 It follows from Figure 8 that the total effect of the five modifications is an apparent recovery of only 19%.
Discussion
Experimental validation of enzymatic estimation of ischemic myocardial injury in the dog has been attempted soon after the introduction of enzyme tests in the clinical diagnosis of acute myocardial infarction.24 26 These studies were based on the marker enzymes aspartate aminotransferase and lactate dehydrogenase and demonstrated significant correlations between the extent of injury and peak activities in plasma. Calculation of total release of enzyme into plasma was not attempted at that time. A more quantitative comparison was made in a study by Shell et al. 27 This study and subsequent validation studies were all based on the enzyme CK. Authors who have since compared total CK depletion from In the present study, the recovery in plasma was determined for two cardiac enzymes, CK and HBD, which are frequently used in the literature as marker enzymes for ischemic heart injury. A detailed map of myocardial enzyme activity demonstrated a close correlation between flow reduction and subsequent loss of CK and HBD from the heart, which allowed definition of the ischemic area in terms of enzyme depletion. After correction for the development of edema, it was found that the enzyme activities lost from the heart are completely recovered in plasma. This result is seemingly in conflict with the results obtained in the quoted validation studies. As discussed below, however, most of these studies have in fact produced data consistent with the present study, FIGURE 7 . Scatterplots of correlations between total activities depleted from the heart and total activities released in plasma, both expressed in gram-equivalents of myocardium. Linear regression equations are CK-rel=0. 95 CK-depl+0.02 and HBD-rel=1.23 HBD-depl-0.92. 10 15 20 25 HBD-DEPL. (G-EQ) and the apparent discrepancies are caused by the methods applied in the analysis of data.
Underestimation of the Rate of CK Elimination From Plasma
Different methods have been used in the literature to estimate the rate of elimination of CK activity from plasma. Some authors have used the apparent disappearance constant kd, measured during the period after the time of peak activity, for FCRCK.
During the elimination phase of CK activity from plasma, however, release of CK continues after the time of peak activity, and there also is resupply of activity from the extravascular pool to plasma. Due to these two factors, the value of kd is much lower than FCR.30 In fact, values of kd after coronary occlusion in the dog are about 0.1/hr, whereas FCRCK is of the order of 0.3/hr. 15, 31, 32 If the values of kd used in some studies (i.e., kd=0.09/hr13 and kd=0.11/hr10) are replaced by the value of FCRCK=0.36 hr, the recoveries of about 20%, as found in these studies, are changed to about 70% (i.e., close to the value found show that the recovery apparently decreases from 95% to 19% if, using the same set of data, vanious corrections are not performed. CK-REL. (G-EQ) 0 in the present study without correction for edema) ( Table 2 ). Other authors estimated FCRCK by measurement of the plasma disappearance rate of CK activity after intravenous bolus injections or infusions of CK preparations. 15, 16, 2731, 32 This method may also introduce errors because the preparation may contain labile fractions causing spuriously high initial elimination rates.815 However, such errors can be avoided and from these studies a consistent value of FCRCK between 0.29 and 0.36/hr has been obtained in the dog. It was also demonstrated that this rapid elimination of (radiolabeled) CK was not altered in the acute phase (12 hours) after occlusion of the LAD.31,33 The present study demonstrates a similar value for FCRCK after 48 hours of LAD occlusion.
Effect of Edema in Infarcted Area
The effect of tissue edema has not been accounted for in the validation studies mentioned, and apart from overall underestimation of recovery, several effects reported in the literature are probably related to it. For instance, it was noted that calculated recoveries were lower in large infarctions.1028,29 As shown in Table 2 this phenomenon also is apparent in the present study if no correction for edema is applied. Edema formation is more extensive in large infarctions and enzyme depletion is overestimated accordingly. This could explain why diffuse infarctions, obtained by embolization with microspheres, showed higher recoveries than infarctions produced by coronary artery occlusion.10 It has also been shown that ligation of cardiac lymphatics resulted in diminished recovery of CK,13 and this procedure would probably have resulted in increased tissue edema.
Importance of a Detailed Map of Myocardial Enzyme Depletion
In the literature, myocardial CK depletion has usually been determined in whole ventricular homogenates. As shown in Figure 8 , this procedure causes increased scatter. The individual variation of 6-7% in control activities (Table 1) introduces a corresponding uncertainty in total left ventricular enzyme activity. This uncertainty implies a considerable error because the total depletion due to infarction is less than 15% of total left ventricular CK activity (Table 1) . We, therefore, limited the measurement of enzyme depletion to the infarcted area with an overall depletion of about 40%. Even so, a 20% error in calculated depletion cannot be avoided ("Results"). The use of whole ventricular homogenates also entails the risk of incomplete extraction of enzyme activity from myocardial tissue. Depletions of more than 40% of total ventricular CK activity after occlusion of the LAD, as reported in several studies, thus can be explained. Such large depletions are also unlikely because the total perfusion area of the LAD is estimated at only 30% of the left ventricle,19 and the infarcted area is only partially depleted. Incomplete extraction of enzyme activity is a risk even for the radical destruction procedure, using both ultraturrax and sonification, applied in the present study. It can be avoided only by reduction of sample size to less than 5 g ("Methods").
The 15% depletion criterion, used in the definition of the infarcted area, is arbitrary and could influence calculated depletion. To check this possibility, the calculations in Tables 1 and 2 were repeated for infarcted areas defined with a 10% and 20% depletion criterion. The resulting mean recoveries, corrected for edema, were 92% and 106% for CK and 105% and 122% for HBD, respectively. The differences between these values and the values presented in Table 2 are small as a result of the steep activity gradients in the border zones shown in the inserts of Figure 3 .
One-Compartment Versus Two-Compartment Models
Recalculation of cumulative enzyme release from our data with the one compartment model produces a mean recovery of 80% instead of 100% ("Results" and Figure 8 ). This limited effect of the choice of model in the present study is caused by the high values of FCR for both CK and HBD. Transcapillary escape occurs at a rate of only about 10% of catabolic elimination (TERP0.03/hr and FCR-0.30/hr); this limits the influence of the extravascular compartment. For slowly catabolized enzymes (i.e., in humans, FCRHBD=0.015/hr), the discrepancies between results obtained with the two models are more important, especially in the estimation of FCR values.30
Comparison With Histologic Estimates of Infarct Size
Several relations have been developed in the literature that compensate for incomplete recovery of CK by multiplication of calculated CK release by an empirical proportionality constant. The original expression derived by Shell et a127 has been used frequently. In this formula, the distribution space for CK is assumed to be about 2.5 times larger than the plasma volume, and actually calculated release of CK is multiplied by a factor of 3.3 to account for a supposed recovery of only 30%. In a subsequent study,8 it was recognized that the distribution space of CK is much smaller and the same proportionality constant now implied a recovery of 15%. If the true recovery would be 100%, as shown in the present study, this procedure would imply an overestimation of infarct size by a factor of 100/15=6.7. Indeed, several studies using this proportionality constantl1128,29 have reported enzymatic overestimations by a factor of 4-10 of histologically assessed infarct sizes up to about 20 gram-equivalents of tissue (i.e., the same range as observed in the present study). Again, the actual data in these reports are consistent with the present study, but the calculations caused a discrepancy.
Comparison With Clinical Validation Studies
Errors as mentioned above have also occurred in clinical validation studies. For instance, the release of CK in plasma was underestimated by the use of apparent disappearance constants instead of FCRCK,5'6 and the loss of CK from the heart has been overestimated by assuming homogeneous CK depletion of the total infarcted area, as defined by NBTstaining or microscopy.57 After correction for these circumstances, it was concluded that the clinical data are roughly consistent with complete recovery. 34 Earlier it has been noted that enzymatic estimates of infarct size in patients with acute myocardial infarction, expressed in gram-equivalents of myocardium, included values up to 30% of the total left ventricle also in patients without severe heart failure.'6 This made significant underestimation of infarct size unlikely.
Implications for Choice of CK and HBD as Marker Enzymes
The present study indicates that both CK and HBD can be used as quantitative markers of ischemic myocardial injury. Several factors, however, may still influence the choice of either of these enzymes. Accumulation of blood cells in the infarcted area is a potential hazard in the use of HBD because these cells contain HBD and not CK. However, Figures 2  and 3 show that tissue depletion of HBD and CK run strictly parallel, and this excludes a significant contribution of tissue HBD from blood cells. Moreover, the release in plasma of CK and HBD occurs in proportion to the myocardial activity of both enzymes ( Figure 6 ). This has also been demonstrated in clinical studies'6,17 and again excludes extra release from blood cells. The absence of this effect can also be understood quantitatively. Total hemorrhage in the infarcted area, also in reperfused infarctions, is estimated at 3-6% of tissue volume. 35, 36 Packed erythrocytes have an HBD content of about 30 units/m137 versus about 180 units/ml for myocardium. These figures imply that erythrocytes contribute less than 1% of tissue HBD content, and the contribution of leukocytes must be even much smaller. 37 A real disadvantage of HBD is error due to hemolytic plasma samples. The HBD content of about 15,000 units/I of blood implies that hemolysis may cause large elevations of plasma HBD activity,37 and strict elimination of hemolytic plasma samples is required ("Methods"). The use of CK, on the other hand, may be complicated by skeletal muscle damage. In the present study, for instance, considerable release of skeletal muscle CK was observed in some dogs resuming physical activity after some hours of complete immobilization due to anesthesia. In clinical studies, HBD has the important advantage of its slow elimination from plasma (FCRHBD [humans] = 0.015/hr), allowing sparse sample schedules and accurate calculation of cumulative release. 30 In the dog, however, this advantage vanishes because HBD and CK are eliminated about equally rapid.
Limitations of Present Study
The significance of myocardial enzyme release with respect to the extent of cell death or in relation to histologic estimates of infarct size is not considered in the present study. Many reports in the literature indicate that enzyme leakage from the heart reflects irreversible cellular injury, but other studies suggest that cells may survive despite temporary loss of intracellular proteins. No universal answers have been obtained in this field, but clinical as well as experimental evidence shows that myocardial release of enzymes in plasma reflects serious, if not always lethal, cellular stress.
We also did not study reperfusion of ischemic myocardium. The no-reflow situation in permanent ischemia can be expected to be the worst possible condition for complete enzyme recovery, but it remains to be proven that such complete recovery is also obtained after reperfusion. The influence of various corrections used in the present study, such as correction for tissue edema, may be quite different in the reperfusion setting.
The two-compartment model is also obviously a simplification of the physiologic situation. Moreover, the model contains a few specific assumptions, such as absence of extravascular elimination of enzyme activity and direct entry of enzymes from heart to plasma. (See Reference 30, chapter 4, for a full discussion of alternative models.) As discussed in the preceding sections, however, the influence of extravasation of CK and HBD is relatively small, and intravenous infusions and bolus injections of enzymes in the dog have shown that the two-compartment model allows accurate calculation of cumulative enzyme release in plasma. 16'18'30 
